Dr. Gulhati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany Street
New Brunswick, NJ 08901Phone+1 732-235-3551
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2014 - 2015
University of Texas Medical Branch School of MedicineClass of 2006
Certifications & Licensure
NJ State Medical License 2019 - 2025
TX State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy Start of enrollment: 2022 Jul 29
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers.Reagan M Barnett, Albert Jang, Sree Lanka, PIngfu Fu, Leslie A Bucheit
Communications Medicine. 2024-12-02 - Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers.Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, Mehrie Patel, Benjamin A Weinberg
JCO Precision Oncology. 2024-08-01 - 1 citationsMolecular Landscape and Therapeutic Strategies against Colorectal Cancer.Aakash Patel, Pat Gulhati
Cancers. 2024-04-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
